Viewing StudyNCT03721172



Ignite Creation Date: 2024-05-06 @ 12:17 PM
Last Modification Date: 2024-10-26 @ 12:56 PM
Study NCT ID: NCT03721172
Status: COMPLETED
Last Update Posted: 2024-05-29
First Post: 2018-10-09

Brief Title: Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo an Analysis of Clinical Safety and Efficacy
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Psoriasis
Keywords:
Name View
Phase 3 View
Double-Blind View
Efficacy View
Safety View
Apremilast View
Otezla View
CC-10004 View
Plaque Psoriasis View
Mild View
Moderate View
Scalp View
Nail View
Itch View